Survival analysis by Wardak, Mohammad Alif
California State University, San Bernardino 
CSUSB ScholarWorks 
Theses Digitization Project John M. Pfau Library 
2005 
Survival analysis 
Mohammad Alif Wardak 
Follow this and additional works at: https://scholarworks.lib.csusb.edu/etd-project 
 Part of the Mathematics Commons 
Recommended Citation 
Wardak, Mohammad Alif, "Survival analysis" (2005). Theses Digitization Project. 2810. 
https://scholarworks.lib.csusb.edu/etd-project/2810 
This Thesis is brought to you for free and open access by the John M. Pfau Library at CSUSB ScholarWorks. It has 
been accepted for inclusion in Theses Digitization Project by an authorized administrator of CSUSB ScholarWorks. 
For more information, please contact scholarworks@csusb.edu. 
SURVIVAL ANALYSIS
A Thesis
Presented to the
Faculty of
California State University,
San Bernardino
In Partial Fulfillment
of the Requirements for the Degree
Master of Arts
in
Mathematics
by
Mohammad Alif Wardak
December 2005
SURVIVAL ANALYSIS
A Thesis
Presented to the'
Faculty of
California State University,
San Bernardino
by
Mohammad Alif Wardak
December 2005
Approved by:
Dr. Charles Stanton, Advisor, 
Department of Mathematics
f 2-// jxdO
Date
Dr. Peter Williams, Chair 
Department of Mathematics
J t 4ed|xeJ'f-
Dr. Terry Hallett, 
Graduate Coordinator 
Department of 
Mathematics,
ABSTRACT
The tools used in survival analysis are the Kaplan-
Meier Estimator, a non-parametric statistic, and the Cox
Proportional Hazard method. The Kaplan-Meier method
estimates the survival curve taking into account censored
data. Cox Proportional Hazard results include total
values/censored values, covariate non-parametric estimate,
standard error, chi-square statistic, P-value, and hazard
ratio. We used the Mayo Clinic study of 418 Primary
Biliary Cirrhosis patients during a ten-year period. In
using these methods we found that the Kaplan-Meier
survival curves were significantly different between the
groups. Kaplan-Meier results include total values/censored
values.
The results indicate that drugs did not have a major
difference on the outcome of the tests. Gender was the
substantial determining factor.
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CHAPTER ONE
INTRODUCTION TO SURVIVAL ANALYSIS
The term "survival analysis" pertains to a
statistical approach designed to take into account the
amount of time an experimental unit contributes to a
study. That is, it is the study of time between entry into
observation and a subsequent event. In survival analysis
we observe the length of time from a starting point (such
as the date of a hospital admission) until the occurrence
of an endpoint event (such as death), often referred to as
a "failure." A key characteristic of survival analysis is
the inclusion of partially missing (so-called "censored")
data. For example, if a woman is alive at study's end we
do not know how long she is going to live; however if her
start point occurred 180 days earlier, we do know that her
survival time is at least 180 days. Loss to follow-up, and
"closing the files" when a study ends are common censoring
events.
There are two aspects of survival analysis that make
it interesting from a data analysis perspective which are:
1. The response variable, time to failure, is
usually not normally distributed.
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2. Survival analysis often involves censored data.
Originally the event of interest was death, hence the
term, "survival analysis." The analysis consisted of
following the subject until death. The uses in the
survival analysis of today vary quite a bit. Applications
now include time until onset of disease, employment,
equipment failure, earthquake, and so on. The best way to
define such events is simply to realize that these events
are a transition from one discrete state to another at an
instantaneous moment in time. Of course, the term
"instantaneous", which may be years, months, days,
minutes, or seconds, is relative and has only the
boundaries set by the researcher.
The origin of survival analysis goes back to
mortality tables from centuries ago. However, it was not
until World War II that a new era of survival analysis
emerged (See,[8]). This new era was stimulated by interest
in reliability (or failure time) of military equipment. At
the end of the war these newly developed statistical
methods emerging from strict mortality data research were
applied to failure time research, and quickly spread
through private industry as customers became more
demanding of safer, more reliable products. As the uses of
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survival analysis grew, parametric models gave way to
nonparametric and semi parametric approaches because of
their appeal in dealing with the ever-growing field of
clinical trials in medical research. Survival analysis was
well suited for such work because medical intervention
follow-up studies could start without all experimental
units enrolled at the start of the observation time and
could end before all experimental units had experienced an
event. This is extremely important because even in the
best-developed studies there will be subjects who choose
to quit participating, who move too far away to follow, or
who will die from some unrelated event. The researcher was
no longer forced to withdraw the experimental unit and all
associating data from the study; instead techniques called
censoring enable researchers to analyze incomplete data
due to delayed entry or withdrawal from the study. This
was important in allowing each experimental unit to
contribute all of the information possible to the model
for the amount of time the researcher was able to observe
the unit.
Current software packages and high performance
computers now make applying survival analysis techniques
3
easier to solve because of their computationally intensive
algorithms.
Some of the tools used in survival analysis are the
cumulative distribution function F(t) , the probability
density function f(t), the survival function S(t) , and the
hazard function, h(f) . The survival function data is
generally described and modeled in terms of two related
functions, the survivor function and hazard function. The
survivor function, S(t) , represents the probability that an
individual survives from the time origin to some time
beyond t, it is positive and ranges from 0 to 1. It is
defined as 5(0) = 1 and as / approaches °o , 5(/) approaches 0.
The survivor function can be estimated non-parametrically
from observed data, both censored and uncensored, using
the Kaplan-Meier method. This method is also called the
product-limit method and is based on maximum likelihood
estimation. Suppose deaths occur at times tx < t2... < tn .
The Kaplan-Meier estimator is the estimator used by most
software packages because of the simplistic step idea. The
Kaplan-Meier estimator incorporates information from all
of the observations available, by considering any point in
4
time as a series of steps defined by the observed survival
and censored times.
t
S(t) = p(T >0 = 1 -F(/) = l- \f(u)du
K=0
The above survival curve describes the relationship
between the probability of survival- and time.
The cumulative distribution function is very useful
in describing the continuous probability distribution of a
random variable, such as time, in a survival analysis. The
cumulative distribution function of a random variable T ,
denoted by Ft(t), is defined by Ft (t) = Pt(T < t). This is
interpreted as a function that will give the probability
that the variable T will be less than or equal to any value
t that we choose. Several properties of a distribution
function F(t) can be listed as a consequence of the
knowledge of probabilities. Note that F(t) has the
probability 0 < F(t) < 1, and F(t) is a non-decreasing
function of t, and as / approaches °o , F(t) approaches 1.
The resulting function is also called the survivorship or
survival function. The hazard function A(/)is given by the
following:
h(i) = P{t < T < (/ + A) | T > t} = /(/) /(I - F(/)) = f(t) / S(t)
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The hazard function describes the concept of the risk of
an outcome (e.g., death, failure, hospitalization) in an
interval after time t, conditional on the subject having
survived to time t . It is the probability that an
individual dies at somewhere between t and t + A, divided by
the probability that the individual survived beyond time t .
The hazard function seems to be more intuitive to use in
survival analysis than the probability density function
because it attempts to quantify the instantaneous risk
that an event will take place at time t given that the
subject survived to time t (See, [8], [9]).
The survivor function and hazard function can be
estimated from observed data. If the form of F(t) is not
specified then non-parametric procedures can be used,
otherwise parametric models can be fitted to the data.
The probability density function is also very useful in
describing the continuous probability distribution of a
random variable. Every continuous random variable has its
own density function, the probability P(a<T<b) is the area
under the curve between times a and b.
Censoring or incomplete data in survival analysis
experiments are designed for a shorter period of time
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only, and, have to account for the lost observations. If
we observe a sample only for a short period of time, we
only know that some individuals were alive at the end of
the survey and no information on their exact time of death
is available. Similarly if observations are lost during
the experiment, all we know is that these individuals were
still alive at some stage and no information on their
exact time of death is available.
Data are called right-censored if the current survey
ends at a fixed date known in advance. If the event of
interest happens after this date, the observation is
censored. All we know in this case is that the event might
have happened after the end of the survey. Data are called
left-censored if no information on the date at which the
event of interest occurred is available. All we know in
this case is that a certain disease occurred before the
examination. Survival in two or more groups of patients
can be compared using a non-parametric test such as the
log-rank test, also called the Mantel-Cox test. This is
the most widely used method of comparing survival curves.
There are several reasons Cox's proportional hazards
modeling was chosen to explain the effect of covariates on
time until event. They are the relative risk non
7
parametric assumptions, the use of the partial likelihood
function, and the creation of survivor function estimates.
The non-parametric tests for comparing survival in
the Mantel-Cox method essentially calculate at each death
time, for each treatment group, the expected number of
deaths under the null hypothesis of no difference between
groups. These are then summed to give the total expected
number of deaths in each treatment group, say E, for
treatment group i . The log-rank test for data compares the
observed number of deaths in each treatment group, say 0,
for treatment group i, to the expected number by
calculating the test statistic
2 S(0._Ei)2
x2=Z
i=i Ei
and comparing it to a chi-square distribution with g-1
degrees of freedom, where g is the number of treatment
groups.
Nonparametric methods provide an alternative series
of statistical methods that require no or very limited
assumptions to be made about different circumstances. Some
of the more commonly used are the nonparametric
alternatives to the /-tests, and it is these that are
covered in the present review.
8
EPI-Info™ version 3.3.2 is the software package used
in Chapters 3 and 4, especially for Cox Proportional
Hazard. EPI-Info is a public domain software package
designed for the global community of public health
practitioners and researchers. It provides for easy form
and database construction, data entry, and analysis with
epidemiologic statistics, maps, and graphs. Minitab 14 was
used in Chapter 1 and 2 for Kaplan-Meier Estimator
(See,[14]).
9
CHAPTER TWO
KAPLAN-MEIER ESTIMATOR
The Kaplan-Meier estimate is a simple way to compute
the survival curve. It involves computing the number of
people who died at a certain time point, divided by the
number of people who were still in the study at that time.
These probabilities are multiplied by any earlier computed
probabilities, which is one reason this is called a
"product limit estimate." The Kaplan-Meier survival curve
is often illustrated graphically. It looks like a poorly
designed staircase, with vertical steps downward at the
time of death of each individual subject (See Appendix D).
Often we will compare curves for two different groups
of subjects. For example, the survival pattern for
subjects on a standard therapy may be compared to a newer
therapy. We can look for gaps in these curves in a
horizontal or vertical direction. A vertical gap means
that at a specific time point, one group had a greater
fraction of subjects surviving. A horizontal gap means
that it took longer for one group to experience a certain
fraction of deaths.
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To compute a survival curve, we need to note the time
of occurrence of events (e.g., failures, deaths) and letI
/,,/2,/3,... represent the times when a death or failure occurs.
It is possible for two or more events to occur at the same
time, in which case the number of distinct times is less
than the number of deaths or failures. We need to place
the t's in order from smallest to largest, that is,
tx<t2<t2< ....
We also need to define the starting point of the study,
Zo = 0 . The basic computations for the Kaplan-Meier survival
curve rely on the computation of conditional survival 
probabilities. In particular, the probability P[Y>/(.|7’>/_t]
which can be interpreted as the probability of a subject
survival to a specific time, given that the subject
survived to the previous time. This probability is easy to
calculate if we know the number of deaths or failures at a
specific time and if we also know the number of patients
at risk at that time.
A more difficult (but more important) probability is
the unconditional probability of survival, P[Y>/.] which
represents the simple probability of survival to a
11
Armed with this information we can now compute a Kaplan-
Meier survival curve. First we need to calculate the
number of patients at risk, ni =ni_A-- c(._j . In other words,
the number at risk at any specific time point is just the
number at risk at the previous time point, minus the
number of deaths/failures and the number of censored
observations. For convenience, we define n0 to be the total
number of patients in the study, c0 to be the number of
censored observations prior to the first death or failure,
and d0 = 0 . Next we compute the estimate of the conditional
probability of survival: (See, [1], [9]).
p[r>r; raz,..,]-!-!-
Finally, the unconditional probability of survival is
simply the cumulative product of the conditional
probabilities.
p[r>
Censoring
Censoring is a key concept for survival analysis.
Censoring is a form of missing data. In an experiment in
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which subjects are followed over time until an event of
interest (such as death or other type of failure) occurs,
it is not always possible to follow every subject until
the event is observed. An event is usually death (but
other events used in the literature include hospital
discharge, development of a disease, and relapse of a
malignancy). The event is also referred to as a failure.
Subjects may drop out of the study and be lost to follow­
up, or be deliberately withdrawn, or the end of the data
collection period may arrive before the event is observed
to happen. For such a subject, all that is known is that
the time to the event was at least as long as the time to
when the subject was last observed. The observed time to
the event under such circumstances is censored. Survival
analysis methods generally allow for censored data.
Censoring may occur from the right (observation stops
before the event is observed) as in censorship for
survival analysis, or from the left (observation does not
begin until after the event has occurred).
Suppose that the following Primary Biliary Cirrhosis
data are observed from 15 («=15) with Platelets. Seven
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patients relapse at 9.7, 10.3, 10.6, 11, 12, 12.2, 13.6,
months.
The Kaplan-Meier estimates can be calculated by
constructing a table with five columns following the
outline below.
1. Column 1 contains all the survival time, both
censored and uncensored in order from largest to
smallest.
2. The second column, labeled i, consists of the
corresponding rank of each observation in
column 1.
3. The third column, labeled r, pertains to
uncensored observations only. Let r=i.
4. Compute («-r)/(n-r + l), or p(., for every uncensored
observation Z(;) in column 4 to give the
proportion of patients surviving up to and then
through .
5. In column 5, S(t) is the product of all values of
(n-r)/(n-r + Y) up to and including t . If some
uncensored observations are ties, the smallest
S(t) should be used.
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To summarize this procedure, let n be the total number of
patients whose survival times, censored or not, are
available. Re-label the n survival times in order of
increasing magnitude such that /(1) </(2) <... </(n) . Then
<S(O = T"r---------- where r runs through those positive integers
jln-r+l
for which /(r) <t and t(r) is uncensored. The values of r are
consecutive integers 1,2,...,n if there are no censored
observations; if there are censored observations, they are
not counted. The estimated median survival time is 50
percentile, which is the value of t at S(t) = 0.50. See
Appendix B for an example of the calculation of a Kaplan-
Meier estimate. For calculations by Minitab (see Appendix
C) and for graph of Kaplan-Meier regarding survival curves
of genders, (see Appendix D).
Log - Rank Test
Often it is of interest to determine whether two or
more samples could have arisen from identical survivor
functions. One approach would involve the use of the
asymptotic results for F(t) mentioned above to devise a
test for equality of the survivor functions at some pre­
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specified time t. Such a procedure, however, would not
usually make efficient use of the available data, and
attention in recent years has turned instead to test
statistics that attempt to summarize differences between
survivor function estimators over the whole of the study
period. The log-rank test is particularly good when the
ratio of hazard functions in the populations being
compared is approximately constant. It can also be
advocated on the basis of ease of presentation to non-
statistical personnel since the test statistic is the
difference between the observed number of failures in each
group. It is a quantity that, for most purposes, can be
thought of as the corresponding expected number of
failures under the null hypothesis (See, [2], [4]).
Suppose one wishes to test the equality of the
survivor functions Fx(t),...,Fr(t) on the basis of samples from
each of r populations. Let /, < t2 tk denote the failure
times for the sample formed by pooling the rindividual 
samples. Suppose d- failures occur at tjand the n,j study
subjects are at risk just prior to /.(y =1,...,&) and let d-and
7JI?.be the corresponding numbers in sample i (i = l,...,r) . The
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data at f are in the form of a 2xr contingency table with 
dy failures and ny-dy survivors in the i th row (z' = l,..,r).
Conditional on the failure and censoring experience up to 
time /.the distribution of dxj,...,drj is simply the product of
binomial distributions
n
1=1
y |V,.(1-2,.)"^ (2.1)
where 2.is the conditional failure probability at f which
is common for each of the r samples under the null
hypothesis. The conditional distribution for dXj,...,drj given
dj is then the hyper-geometric distribution
n
Au
The mean and variance of dt~ from (2.1) are, respectively,
= nydjnf' and (F.)ff = -tiyjdfnj-d^nf2^. -I)’1
The covariance of dy and dy is (Vj)a =-nynydfn -djffij 2(rij-V)
Thus the statistic v j = (dy-Wy,...,drj. -wry.)has (conditional) 
mean zero and variance matrix Vj, where the prime denotes
18
vector transpose. See Appendix E for an example of the
log-rank test.
19
CHAPTER THREE
COX PROPORTIONAL HAZARD REGRESSION MODEL
The Cox proportional Hazard model is probably the
most widely used method for modeling survival data. For
data with one explanatory variable, i.e. one covariate,
non-parametric methods like plotting Kaplan-Meier survival
probabilities may be adequate if the groups being compared
are reasonably similar. Frequently however, the groups
being compared differ in many respects. They may have
different age distributions, different proportions of men
and women, different smoking habits etc. These differences
come in addition to the covariates we are really
interested in, and the analysis must be adjusted to
compensate for these other differences, which may
otherwise confound the analysis. The Cox proportional
hazards model is a semi-parametric model for fitting
survival data. The basic model is as follows:
A(z|Z) = /z0(f)-exp(^Z)
where h0(t) is the baseline hazard which may vary
arbitrarily over time, and z is the covariate vector. The
covariates may be time-dependent but are fixed at the
20
start of the study. The vector ft - {/3x,...,Pn) is a vector of
covariate coefficients. The baseline hazard is treated
non-parametrically, but the individual covariate effects 
(J3p) are assumed to be constant throughout the study. The
model is often called the proportional hazards model
because of this constant covariate effect throughout the
study. If two individuals are compared that have covariate
values Z and Z* the ratio of their hazard rates at any
time point simplifies to
/i,/z)exp[y/3Z,] ,
-----------a------ = exp[2A(Z« -4')]
A,(()exp[£>?z;] *■'
k=l
This ratio is constant or "proportional" throughout the
study. This assumption greatly facilitates the
interpretation of covariate effects, as the effect of a
given covariate compared to the absence of that covariate
is expressed as a single constant. This does not however
imply that the absolute difference between the two
individuals discussed above is constant; the exponentiated
covariates act multiplicatively on a baseline hazard which
may vary freely (See, [3]).
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Cox Model with Several Covariates
Fitting of the multivariate Cox proportional hazards
model would be conducted by starting with a model with all
variables listed above. One by one, the least significant
variable would be removed until only significant variables
remained in the model. Data for overall survival was
modeled in the same way. (See,[5]).
The Assumption of Proportional Hazards
Since the Cox proportional hazards model relies on
the hazards to be proportional, i.e. that the effect of
given covariate does not change over time, it is very
important to verify that the covariates satisfy the
assumption of proportionality. If the assumption is
violated, the simple Cox model is invalid, and more
sophisticated analyses are required. If the interest
centers upon a binary covariate, Z, whose relative risk
changes over time, one approach is to introduce a time-
dependent covariate as follows. Let
Z, if the covariate Zj takes on the value 1
a
22(0 =
if the covariate Zj takes on the value 0,0
22
where g(i) is a known function of time. In such cases, it
may be preferable to use a procedure that would allow the
function g(f) to be estimated from the data. One approach
to this problem is to fit a model with an indicator
function for gif) . In the simplest approach, define a time-
dependent covariate Z2(/) = if t>r 
if t<r
To determine the optimal value of t , the model
including the new covariate zfit) is fitted for a set of
values for t , and the value of the maximized log partial
likelihood is the optimal value to use. Proportional
hazards can, then, be tested for each region and if it
fails, for t on either side of r then this process can be
repeated in that region.
The assessment of the proportional hazards assumption
can be done numerically or graphically. A great number of
procedures have been proposed over the years. Some of the
procedures require partitioning of failure time, some
require categorization of covariates, some include a
spline function, and some can be applied to the
untransformed dataset. None of the methods, either
numerical or graphical, are today known to be better than
23
the others in finding out whether - the hazards are
proportional or not. Some authors recommend using
numerical tests and others recommend graphical procedures
since they believe that the proportional hazards
assumption only approximates the correct model for a
covariate and that any formal test, based on a large
enough sample, will reject the null hypothesis of
proportionality.
Maximum Likelihood
The likelihood and log-likelihood functions are the
basis for deriving estimators for parameters, given data.
While the shapes of these two functions are different,
they have their maximum point at the same value. In fact,
the value of 0 that corresponds to this maximum point is
defined as the Maximum Likelihood Estimate and that value
is denoted as 0 . This is the value that is "most likely"
relative to the other values. This is a simple, concept
and it has a host of good statistical properties. Thus, in
general, we seek 0 such that this value maximizes the log-
likelihood function (See, [4], [7]).
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Generally, the calculus is used to find the maximum
point of the log-likelihood function and obtain Maximum
Likelihood Estimations in closed form. This is tedious and
often not useful in real problems (where closed form
estimator may often not even exist). The log-likelihood
functions we will see have a single mode or maximum point
and no local optima. These conditions make the use of
numerical methods appealing and efficient. (See,[6]).
Consider first, the binomial model with a single
unknown parameter,#. Using calculus one could take the
first partial derivative of the log-likelihood function
with respect to the 0, set it to zero and solve for 0.
This solution will give 0, the Maximum Likelihood
Estimation. This value of 0, is the one that maximizes the
likelihood function. It is the value of the parameter that
is most likely, given the data.
The likelihood function provides information on the
relative likelihood of various parameter values, given the
data and the model (here, a binomial). Think of 10 of your 
friends, 9 of which have one raffle ticket, while the 10th
friend who has 4 tickets, has a higher likelihood of
winning relative to the other 9 friends. If you were to
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try to select the most likely winner of the raffle, which
person would you pick? Most would select the person with 4
tickets. Now, what if 8 people had a single ticket, one
had 4 tickets, but the last had 80 tickets. Surely the
person with 80 tickets is most likely to win (but not with
certainty). In this simple example you have a feeling
about the "strength of evidence" about the likely winner.
In the first case, one person has an edge, but not much
more. In the second case, the person with the 80 tickets
is relatively very likely to win.
The shape of the log-likelihood function is important
in a conceptual way to the raffle ticket example. If the
log-likelihood function is relatively flat, one can make
the interpretation that several (perhaps many) values of p
are nearly equally likely. They are somewhat alike; this
is quantified as the sampling variance or standard error.
If the log-likelihood function is fairly flat, this
implies considerable uncertainty and this is reflected in
large sampling variances and standard errors, and wide
confidence intervals. On the other hand, if the log-
likelihood function is fairly peaked near its maximum
point, this indicates some values of p are relatively very
26
likely compared to others (like the person with 80 raffle
tickets). There is some considerable degree of certainty
implied and this is reflected in small sampling variances
and standard errors, and narrow confidence intervals. So,
the log-likelihood function at its maximum point is
important as well as the shape of the function near this
maximum point.
The shape of the likelihood function near the maximum
point can be measured by the analytical second partial
derivatives and these can be closely approximated
numerically by a computer. Such numerical derivatives are
important in complicated problems where the log-likelihood
exists in 20-60 dimensions. This method's advantage is
that
maximum likelihood provides a consistent approach to
parameter estimation problems. This means that maximum
likelihood estimates can be developed for a large variety
of estimation situations. For example, they can be applied
in reliability analysis to censored data under various
censoring models (See, [10], [11]).
Maximum likelihood methods have desirable
mathematical and optimality properties. Specifically,
27
1. They become minimum variance unbiased estimators
as the sample size increases. By unbiased, we
mean that if we take (infinitely many number of)
random samples with replacement from a
population, the average value of the parameter
estimates will be theoretically exactly equal to
the population, the average value of the
parameter estimates will be theoretically
exactly equal to the population value. By
minimum variance, we mean that the estimator has
a smallest variance, and thus the narrowest
confidence interval, of all estimators of that
type.
2. They have approximate normal distributions and
approximate sample variances that can be used to
generate confidence bounds and hypothesis tests
for the parameters.
Several popular statistical software packages provide
excellent algorithms for maximum likelihood estimates for
many of the commonly used distributions. This helps
mitigate the computational complexity of maximum
likelihood estimation. This method's disadvantage is that,
the likelihood equations need to be specifically worked
.28
out for a given distribution and estimation problem. The
mathematics is often non-trivial, particularly if
confidence intervals for the parameters are desired.
The numerical estimation is usually non-trivial.
Except for a few cases where the maximum likelihood
formulas are in fact simple, it is generally best to rely
on high quality statistical software to obtain maximum
likelihood estimates. Fortunately, high quality maximum
likelihood software is becoming increasingly common.
Maximum likelihood estimates can be heavily biased
for small samples. The optimality properties may not apply
for small samples. Maximum likelihood can be sensitive to
the choice of starting values.
Partial Likelihood
To obtain estimates of the covariate parameters, Cox
developed a nonparametric method he called partial
likelihood. Estimation of the parameter values is then
obtained by use of maximum partial likelihood estimation.
The partial likelihood method based on this assumption is
related to /z0 being undetermined. The intervals between
successive duration times (or failure times) contribute no
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information regarding the relationship between the
covariates and the hazard rate.
This is in contrast to the parametric methods, where the
actual survival times are used in the construction of the
likelihood function. Because the Cox model only uses
"part" of the available data (/z0(/)is not estimated), the
likelihood function for the Cox model is a "partial"
likelihood function, hence the name. To get a sense for
how this works, look at the logic underlying the partial
likelihood method. Consider the data in Appendix F. Here
are the survival times for fifteen cases. Of these fifteen
cases four of them are right-censored and coded 1. All the
tables in the Appendix, 0 represents male, 1 represents
female.
In the Appendix F table, the first case for /, occurs
at 51 follow up days, t2 occurs at 2 64 follow up days, t3
occurs at 611 follow up days, t4 occurs at 7 62, t6 occurs
at 1012 follow up days, /7 occurs at 1217 follow up days,
/8 occurs at 1427 follow up days, /9 occurs at 2466 follow
up days, tn occurs at 2689 follow up days, /14 occurs at
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4079 follow up days, /]5 occurs at 4191 follow up days,
/5,/10,/12, and /13 are censored (See Appendix G) .
• Events can be ordered.
• At /„ all cases are at risk of failing.
• After the first failure, the risk set decreases
by 1.
• The risk set successively dwindles as events
occur.
To motivate the partial likelihood estimator, let
= exp(/?'x;) . The partial likelihood function for these data
would be equivalent to:
LP =
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For a similar illustrative calculation see Appendix G. In
words, this tells us that each of the fifteen cases is at
risk of experiencing an event up to the first failure
time, t5 . After the first failure in the data set, the risk
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set decreases in size by 1; thus, the risk set up to the
second failure time, /10, includes all cases. By the fourth
failure time in the data, t13, the risk set includes only
cases 5, 10, 12, and 13. By the last failure time, only
case 13 remains in the risk set. This exercise shows that
the partial likelihood function is solely based on the
ordered duration times, and not on the length of the
interval between duration times. Also, censored
observations contribute information to the "risk set,"
that is, cases that are surviving to time , but
contribute no information regarding failure times. To be
more formal, suppose we have a data set with n
observations and k distinct failure (event) times. Cox
estimation first proceeds by sorting the ordered failure
times, such that
tx <t2 < ... <tk,
where denotes the failure time for the i th individual.
For censored cases, we define 8. to be 1 if the case is
right-censored, and 0 if the case is uncensored. Finally,
the ordered event times are modeled as a function of
covariates,x .
32
The partial likelihood function is derived by taking
the product of the conditional probability of a failure at
time /, given the number of cases that are at risk of
failing at time . That is to say, given that some event
has occurred, what is the probability the event occurred
to the ith individual from a risk set of size «? More
formally, if we define /?(/.) to denote the number of cases
that are at risk of experiencing an event as time t., that
is, the "risk set," then the probability that the j th case
will fail at time f is given by
L e
(3.1)
MO
where the summation operator in the denominator is summing
over all individuals in the risk set. Taking the product
of the conditional probabilities in (3.1) yields the
partial likelihood function (a similar example can be
found in [5], [6]),
RR(ii)
with corresponding log-likelihood function,
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/=!
-tog 2 ep' (3.2)
By maximizing the log-likelihood in (3.2), estimates of 
the f3 may be obtained. What is the importance of this
result?
• Specifying the baseline hazard, Zz0(/) is
unnecessary.
• The interval between events does not inform the
partial likelihood function.
• Censored cases contribute information only
pertinent to the risk set (i.e. the denominator,
not the numerator)
The critical thing here is to note that no assumptions
about the shape of the baseline hazard need to be made.
Another way to see this is to think about the heuristic
partial likelihood function above. All we need to know to
compute a probability is ys (orexp(/?'*,)) .
Cox demonstrated that maximum partial likelihood
estimation produces parameter estimates that have the same
properties as maximum likelihood estimates. This is
convenient because under the same set of regularity
conditions as maximum likelihood estimation the parameter
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estimates from partial likelihood are asymptotically
normal, asymptotically efficient, consistent, and
invariant. So the usual kinds of hypothesis tests
discussed in the context of parametric models are directly
extended to the Cox model. The first step in applying the
results of the Application to the primary biliary
cirrhosis data is to order the survival times from
smallest to largest. Appendix G shows an example of this
data. The partial likelihood for ft is now formed by taking
the product over all failure points to give
( \
£W=fl
(=1
exp(z([)/7)
S exP(zz^)
k/eZ!(r,.) ,
The partial likelihood is not a likelihood in the
usual sense in that the general construction does not give
a result that is proportional to the conditional of
marginal probability of any observed event. This is an
example of a partial likelihood to be found in Appendix G.
pp ■- __________________ ______________________
(6ep + 9) • (5ep + 9) ■ (4ep + 9)-(4ep + 8) • (V + 6) 
________________ 1________________
(4ep + 5) • (4ep + 4) • (3ep + 4) • (lep + 4) • (Oe^ + 2)
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d
d(PL)"
________________ 2ef_________________
(6ep +9) (5^ +9)(4^ +9) (4^ +8)(4e/’ +6)
_____________ 1______________
(4ep +5) (4^ +4)(3e/' +4)(e/> +4)
_______________ 3?V________________
(6ep + 9)2 (5ep + 9) (4ep + 9) (4^ + 8)(4</ + 6) 
_____________ 1_______________
(4ep + 5) (4ep + 4) (3^ + 4) (ep + 4) 
________________ SApep________________
2{6ep +9)(5^ + 9)2 (4ep +9)(4e/J +8)(4^ +6) 
_____________ 1__________
(4ep +5) (4ep + 4)(3ep + 4)(ep +4) 
_______________ 2e'pep________________
(6ep +9)(5e^ +9)(4e/' +9)2(4ez' +8) (4^ +6) 
_____________ I_______________
(4ep +5)(4ep+4)(3ep + 4)(ep +4) 
_______________ 2AW_______________
(W + 9) (5ep + 9) (4ep + 9) (4ep + 8)2 (4ep + 6) 
_____________ 1_______________
(4ep +5)(4ep + 4)(3ep +4)(ep +4) 
_______________ 2AW_________________
(6ep+ 9)(5ep+ 9)(4ep+ 9)(4ep+ 8)(4ep+ 6)2 
_____________ 1_______________
(4ep +5)(4ep +4~)(3ep +4)(ep +4) 
_______________ 2AW________________
(6ep + 9) (5ep + 9) (4ep + 9) (4ep + 8) (4ep + 6) 
______________1_______________
(4ep + 5)2 (4ep +4)(3ep +4)(ep +4)
_______________ 2AW________________
(W + 9) (5ep + 9) (4ep + 9) (4ep + 8) (4ep + 6) 
______________1_______________
(4ep + 5) (4ep + 4)2 (3ep + 4) (ep + 4) 
________________3e'W________________
2 (fep + 9) (5ep + 9) (4ep + 9) (4ep + 8) (4ep + 6) 
______________1_______________
(4ep + 5) (4ep + 4) (3ep + 4)2 (ep + 4)
_______________ Apep________________
(6ep + 9) (Sep + 9) (4ep + 9) (4ep + 8) (4ep + 6) ’
______________]_______________  g 2875
(4ep + 5) (4ep + 4) (3ep + 4) (ep + 4)2
(3.3)
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PA = 0.2875 if f3 = 0 The first step in applying the results of
the data is to order the survival times from smallest to
largest with the additional convention that failure times
precede censored times. An efficient computer solution to
the problem would require essentially the same
organization of the data set. In general, there is
advantage to begin the calculation at the last failure
time since the risk set can then be formed by adding the
labels of items failing or censored.
Information Matrix-
Fisher information is a key concept in the theory of
statistical inference and is defined in the following 
manner: Let X - (Xx,..., Xf) be a random sample, and let f(X\ff) 
denote the probability density function for some model of
the data, which has parameter vector 0 = (01,...,0k) . Then the
Fisher information matrix I„(0) of sample size n is given by
the kxk symmetric matrix whose ij — th element is given by
the covariance between first partial derivatives of the
log-likelihood,
In^\j = Cov
d^f(X\0) dln/(W|fl) 
d0x ’ d0j
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An alternative, but equivalent, definition for the Fisher
information matrix is based on the expected values of the
second partial derivatives, and is given by
d2\nf\X\0)
dBfidj
Strictly, this definition corresponds to the expected
Fisher information. If no expectation is taken we obtain a
data-dependent quantity that is called the observed Fisher
information. As a simple example, consider a normal
distribution with mean // and variance a2 , where 3 = (ju,cr2)..
The Fisher information matrix for this situation is given
by: ,/„(0) =
0 n_4
It is worth noting two useful properties of the
Fisher information matrix. Firstly, In(0) = nlfd), meaning that
the expected Fisher information for a sample of n
independent observations is equivalent to n times the
Fisher information for a single observation. Secondly, it
is dependent on the choice of parameterization. Suppose
the parameter 6 is changed into another parameter
■q = {rix,...,rik) with iji = gf3) where gt is one-to-one so its
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inverse g^fj/ = di exists. The Fisher information /*(/7) for 
the new parameterization is obtained using the chain rule
= J(rj)TIn(0(r}y)J(ff) , where 7(7) is the Jacobian matrix with 
elements J(rj)y = dg^ff)/dTj^iJ = .
Let T(X) be any statistic and let be its
expectation such that = £[77(Y)] . Under some regularity
conditions, it follows that for all 0,
var(T(Y)) > I d& -4- (3.4)
W
The value of the right hand side of (3.4) is known as the
Information inequality lower bound. In particular, if T(X)
is an unbiased estimator for 0, then the numerator becomes
1, and the lower bound is simply —-—. Note that this
w
explains why In(0) is called the "information" matrix: The
larger the value of In(0} is, the smaller the variance
becomes, and therefore, we would be more certain about the
location of the unknown parameter value. The information
inequality generalizes to the multi-parameter case, where
0 = (0[,...,0k). Let the statistic W(X) be an estimator for some
function g(0) . Then the inequality states that
39
Var(JV(X))>y(O)TIn(6yxy(6) where y(ff) is a kxl column vector with 
elements y(0); = dg(0)/30(.. The Asymptotic Theory involves the
maximum likelihood estimator that has many useful
properties, including re-parametrization-invariance,
consistency, and sufficiency. Further, it follows under
some regularity conditions that the sampling distribution
of a maximum likelihood estimator 3^ is asymptotically
unbiased and also asymptotically normal with its variance-
covariance matrix obtained from the inverse Fisher
information matrix of sample size 1, that is
-»TV/#,///?) /«) as n goes to infinity. The Fisher
information matrix also arises in Bayesian inference.
The log partial likelihood ratio test is not only the
easiest test to compute, but is also the best of the three
tests for assessing the significance of the fitted model.
The computation of information matrix tests for the
multiple proportional hazards regression model requires
matrix calculations. Specifically, we denote the vector of
first partial derivatives whose elements are given as u(JT) .
Under the hypothesis that all coefficients are equal to
zero, and under the mathematical conditions needed for the
partial likelihood ratio test, the vector of scores
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«(O) = k(M,o will be distributed as multivariate normal with
mean vector equal to zero and covariance matrix given by
the information matrix evaluated at the coefficient vector 
equal to zero, 1(0) =/(/?)|^_o . The elements in this matrix are
obtained by evaluating the expressions with the
coefficient vector equal to zero. The score test statistic
is
aWCO)]"1^),
which is distributed asymptotically as chi-square with n
degrees-of-freedom. This statistic can be used to test the
null hypothesis f3 - 0 by using a chi-square test.
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CHAPTER FOUR
PRIMARY BILIARY CIRRHOSIS DATA
Primary biliary cirrhosis is a disease characterized
by inflammatory destruction of the small bile ducts within
the liver. Primary biliary cirrhosis eventually leads to
cirrhosis of the liver. The cause of primary biliary
cirrhosis is unknown, but because of the presence of auto-.
antibodies, it is generally thought to be an auto-immune
disease. Other etiologies, such as infectious agents, have
not been completely excluded. Primary biliary cirrhosis
has a worldwide prevalence of approximately 5/100,000 and
an annual incidence of approximately 6/1,000,000. The
prevalence and incidence appear to be similar in different
regions of the world. About 90% of patients with primary
biliary cirrhosis are women. Most commonly, the disease is
diagnosed in patients between the ages of 40 and 60 years.
(See, [13]).
This data set is a follow-up to the original primary
biliary cirrhosis data set. "Primary biliary cirrhosis:
prediction of short-term survival based on repeated
patient visits." The data from the Mayo Clinic trial in
primary biliary cirrhosis of the liver conducted between
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1974 and 1984 contains a description of the clinical
background for the trial and the covariates. A total of
418 primary biliary cirrhosis patients, referred to Mayo
Clinic during that ten-year interval, met eligibility
criteria for the randomized placebo controlled trial of
the drug D-penicillamine. The first 310 cases in the data
set participated in the randomized trial and contain
largely complete data. The additional 108 cases did not
participate in the clinical trial, but consented to have
basic measurements recorded and to be followed for
survival. Six of those cases were lost to follow-up
shortly after•diagnosis, so the data here are on an
additional 102 cases as well as the 310 randomized
participants.
The data contains only baseline measurements of the
laboratory parameters. This data contains multiple
laboratory results, but only on the first 310 patients.
Some baseline data values in this file differ from the
original primary biliary cirrhosis file, for instance, the
data errors in prothrombin time and age which were
discovered after the original analysis, during research
work on dfbeta residuals. Another major difference is that
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there was significantly more follow-up for many of the
patients at the time this data was assembled.
One "feature" of the data deserves special comment.
The last observation before death or liver transplant
often has many more missing covariates than other data
rows. The original clinical protocol for these patients
specified visits at 6 months, 1 year, and annually
thereafter. At these protocol visits lab values were
obtained for a large pre-specified battery of tests.
"Extra" visits, often undertaken because of worsening
medical condition, did not necessarily have all this lab
work. The missing values are thus potentially informative,
and violate the usual "missing at random" assumptions that
are assumed in analyses. Because of the earlier published
results on the Mayo primary biliary cirrhosis risk score,
however, the 5 variables involved in that computation were
usually obtained, i.e. age, bilirubin, albumin,
prothrombin time, and edema score. The variables used
were: Case number; Number of days between registration and
the earlier of death, trans-plantation, or study analysis
time; Status: 0=alive, l=transplanted, 2=dead; Drug: 1= D-
penicillamine, 0=placebo; Age in days, at registration;
Sex: 0=male, l=female; Day: number of days between
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enrollment and this visit date, remaining values on the
line of data refer to this visit; Serum bilirubin n mg/dl;
Serum cholesterol in mg/dl; Albumin in gm/dl; Alkaline
phosphates in u/liter; SGOT in u/ml (serum glutamic-
oxaloacetic transaminase, the enzyme name has subsequently
changed to "ALT" in the medial literature); Platelets per
cubic ml / 1000; Prothrombin time in seconds; Histologic
J
stage of disease. We used EPI-Info to calculate Kaplan-
Meier for 312 patients Primary Biliary Cirrhosis by Gender
for Age, Albumin, Alkaline, Bili, Platelets, and Spiders
(See Appendix J). The smaller the p-value is, more changes
can be seen affecting the outcomes. The larger the p-value
is, covariates are not significant. In the outcome for 312
patients by Gender there was a noticeable change. In the
outcome for 312 patients by Drug in there was not a
noticeable change (See Appendix L). The smallest p-value
was shown for Age, Albumin, Alkaline, and Bili. The
Coefficient (/?) for Gender was //=-.0804, based on
h(t) = h0(t)e^x indicating that the hazard function for female
is smaller (sex=l), and the male (sex=0) hazard ratio
could be lower with 95 percent confidence (See Appendix
H). The nonparametric survival plot for follow up days by
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Placebo and Penicillamine for 312 patients is illustrated
in Appendix K on the Kaplan-Meier curve for all patients
n = 312 .
We used the nonparametric survival plot for follow up days
by gender for 312 patients. The plot shows the survival
curves for all categories for Primary Biliary Cirrhosis
(See Appendix H). The result of Minitab calculations are
in Appendix I.
We used EPI-Info to calculate Primary Biliary
Cirrhosis by drug for Age, Albumin, Alkaline, Bili,
Platelets, and Spiders for 312 patients (See Appendix L).
In the outcome for 312 patients by Drug there was no
noticeable change. The result in Appendix L show that the
hazard ratio for drugs is not noticeably different. The
hazard rate for the drug was 0.9775. This difference could
be due to the non-linear effect of the drug itself.
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APPENDIX A
DATA OF PRIMARY BILIARY CIRRHOSIS I
47
ID
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
FU Days
321
Status
2
Censor
0
Age
15116
Sex
1
Asictes
0
Trig
158
Platelets
124
552 2 0 18799 0 0 122 119
691 0 1 21185 1 * ★ 269
769 2 0 19060 1 0 128 224
877 1 1 12912 0 0 194 306
890 2 0 24622 0 0 91 360
939 0 1 22767 1 0 100 234
1487 2 0 22977 1 0 188 178
1746 2 0 19724 0 * ★ 325
2033 1 1 12839 0 0 210 344
2386 2 0 18460 0 0 93 362
2400 2 0 15526 1 0 88 251
2576 0 1 17323 1 0 71 356
2689 2 0 12227 0 0 155 337
2812 2 0 18628 1 * * *
3069 0 1 19318 0 0 107 182
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APPENDIX B
CALCULATION OF THE 
KAPLAN-MEIER ESTIMATE
49
Time (/) Rank i r (n -r}/(n-r +1) 5(/)
321 1 1 15/16 0.938
552 2 2 14/15 (0.938)(0.933) = 0.875
691 3 - -
769 4 4 12/13 (0.875)(0.923) = 0.808
877 5 - -
890 6 6 10/11 (0.808)(0.909) = 0.734
939 7 - -
1487 8 8 8/9 (0.734)(0.889) = 0.653
1746 9 9 7/8 (0.653)(0.875) = 0.571
2033 10 - -
2386 11 11 5/6 (0.571 )(0.833) = 0.476
2400 12 12 4/5 (0.476)(0.800) = 0.381
2576 13 - -
2689 14 14 2/3 (0.381 )(0.667) = 0.254
2812 15 15 1/2 (0.254)(0.500) = 0.127
3069 16 - 0 0
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APPENDIX C
CALCULATION OF THE MINITAB 
FOR 15 PATIENTS
51
Kaplan-Meier Estimates
Number
at Number Survival Standard 95.0% Normal CI
Time Risk Failed Probability
Upper
Error Lower
321 8 1 0.875000 
1.00000
0.116927 0.645828
769 6 1 0.729167
1.00000
0.164976 0.405819
1487 4 1 0.546875
0.94000
0.200580 0.153745
2400 3 1 0.364583 
0.75675
0.200086 0.000000
2812 1 1 0.000000
0.00000
0.000000 0.000000
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APPENDIX D
GRAPH OF NONPARAMETRIC SURVIVAL 
PLOT FOR FOLLOW UP DAYS 
FOR 15 PATIENTS
53
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APPENDIX E
CALCULATION OF THE 
LOG-RANK TEST 
FOR 16 PATIENTS
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ti
321
552
691
769
877
890
939
1487
1746
2033
2386
2400
2576
2689
2812
3069
mi ri zn(,.)/r(,.) <*(,))
1 16 0.625 0.625 0.3751 15 0.067 0.692 0.308- - - - -1 13 0.077 0.769 0.231- - - - -1 11 0.909 1.678 - 0.678- - - - -1 9 0.111 1.789 - 0.7891 8 0.125 1.914 - 0.914- - - - -1 6 0.167 2.081 - 1.0811 5 0.200 2.281 - 1.281- - - - -1 3 0.333 2.614 - 0.6141 - - - -
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APPENDIX F
PRIMARY BILIARY CIRRHOSIS 
FOR 15 PATIENTS
57
Patient ID FU Days Status Censor Drug Age Sex Asictes Platelets
1 10 51 2 0 2 25772 1 1 302
2 23 264 2 0 2 20442 1 1 214
3 97 611 2 0 2 26259 0 0 344
4 149 762 2 0 1 22574 0 0 140
5 295 877 1 1 1 12912 0 0 306
6 3 1012 2 0 1 25594 0 0 151
7 14 1217 2 0 2 20535 0 1 156
8 148 1427 2 0 2 11273 1 0 330
9 8 2466 2 0 2 19379 1 0 373
10 190 2504 0 1 1 19916 1 0 327
11 90 2689 2 0 1 12227 0 0 337
12 21 3445 0 1 2 23445 0 0 336
13 16 3672 0 1 2 14772 1 0 198
14 24 4079 2 0 1 16261 0 0 70
15 66 4191 2 0 1 16967 0 0 123
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APPENDIX G
PROPORTIONAL HAZARDS MODEL 
APPLIED TO PRIMARY 
BILIARY CIRRHOSIS
59
Contribution to
Patient FU Days Sex Censored Likelihood
1 51 1 6e^+9
ep
2 264 1 5^+9
1
3 611 0 4^+9
1
4 762 0 0(877) 4^+8
1
6 1012 0 4^+6
1
7 1217 0 4^+5
ep
8 1427 1 4ep + 4
ep
9 2466 1 1(2504) 3^+4
1
11 2689 0 0(3445), 1(3672) le^+4
1
14 4079 0 Oe^+2
I
15 4191 0 0e^+l
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APPENDIX H
NONPARAMETRIC SURVIVAL PLOT 
FOR FOLLOW UP DAYS BY GENDER 
FOR 312 PATIENTS
61
Nonparametric Survival Plot for Follow Up Days
Kaplan-Meier Method 
Censoring Column in Censor
Sex
---------- Male
--------- Female
Table of Statistics 
Mean Median IQR 
2404,23 2386 3179
2773.30 3428 *
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APPENDIX I
MINITAB CALCULATIONS:
PRIMARY BILIARY CIRRHOSIS BY GENDER
FOR 312 PATIENTS
63
Kaplan-Meier Estimates
Number
Time
41
51
71
77
110
130
131
179
186
198
207
216
223
264
304
321
326
334
348
388
400
460
515
549
597
673
694
708
733
750
769
786
790
797
824
850
853
859
904
930
943
971
974
980
1000
1037
1080
1083
1165
1170
1191
1212
1235
1350
1356
at Number Survival Standard 95.0% Normal CI
Risk Failed Probability Error Lower Upper
275 1 0.996364 0.0036297 0.989249 1.00000
274 1 0.992727 0.0051239 0.982685 1.00000
273 1 0.989091 0.0062639 0.976814 1.00000
272 1 0.985455 0.0072196 0.971304 0.99960
271 1 0.981818 0.0080569 0.966027 0.99761
270 1 0.978182 0.0088095 0.960915 0.99545
269 1 0.974545 0.0094977 0.955930 0.99316
268 1 0.970909 0.0101345 0.951046 0.99077
267 1 0.967273 0.0107291 0.946244 0.98830
266 1 0.963636 0.0112882 0.941512 0.98576
265 1 0.960000 0.0118168 0.936840 0.98316
264 1 0.956364 0.0123188 0.932219 0.98051
263 1 , 0.952727 0.0127974 0.927645 0.97781
262 2 0.945455 0.0136941 0.918615 0.97229
260 1 0.941818 0.0141160 0.914151 0.96948
259 1 0.938182 0.0145223 0.909719 0.96664
258 1 0.934545 0.0149143 0.905314 0.96378
257 1 0.930909 0.0152932 0.900935 0.96088
256 1 0.927273 0.0156598 0.896580 0.95797
255 1 0.923636 0.0160150 0.892248 0.95503
254 1 0.920000 0.0163596 0.887936 0.95206
253 1 0.916364 0.0166942 0.883644 0.94908
252 1 0.912727 0.0170194 0.879370 0.94608
251 1 0.909091 0.0173357 0.875114 0.94307
250 1 0.905455 0.0176436 0.870874 0.94004
249 1 0.901818 0.0179436 0.866649 0.93699
248 1 0.898182 0.0182360 0.862440 0.93392
247 1 0.894545 0.0185211 0.858245 0.93085
245 1 0.890894 0.0188020 0.854043 0.92775
243 1 0.887228 0.0190787 0.849834 0.92462
242 1 0.883562 0.0193489 0.845639 0.92148
241 1 0.879896 0.0196129 0.841455 0.91834
240 1 0.876229 0.0198709 0.837283 0.91518
239 1 0.872563 0.0201231 0.833123 0.91200
238 1 0.868897 0.0203698 0.828973 0.90882
235 1 0.865199 0.0206160 0.824793 0.90561
234 1 0.861502 0.0208568 0.820623 0.90238
233 1 0.857805 0.0210925 0.816464 0.89915
231 1 0.854091 0.0213255 0.812294 0.89589
230 1 0.850378 0.0215537 0.808133 0.89262
228 1 0.846648 0.0217795 0.803961 0.88933
227 1 0.842918 0.0220006 0.799798 0.88604
226 1 0.839189 0.0222171 0.795644 0.88273
225 1 0.835459 0.0224293 0.791498 0.87942
223 1 0.831712 0.0226394 0.787340 0.87608
221 1 0.827949 0.0228476 0.783168 0.87273
219 1 0.824168 0.0230540 0.778983 0.86935
218 1 0.820388 0.0232561 0.774807 0.86597
214 1 0.816554 0.0234613 0.770571 0.86254
213 1 0.812721 0.0236623 0.766343 0.85910
212 2 0.805053 0.0240521 0.757912 0.85219
210 1 0.801220 0.0242412 0.753708 0.84873
205 1 0.797311 0.0244360 0.749418 0.84521
195 1 0.793223 0.0246504 0.744909 0.84154
194 1 0.789134 0.0248601 0.740409 0.83786
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1413
1427
1434
1444
1487
1492
1576
1657
1690
1741
1786
1827
1847
1925
2055
2081
2090
2105
2224
2256
2288
2297
2400
2419
2466
2503
2540
2583
2598
2769
2847
3086
3090
3170
3222
3244
3282
3358
3428
3445
3574
3584
3762
3839
3853
188 1 0.784936 0.0250797 0.735781 0.83409
185 1 0.780693 0.0253005 0.731105 0.83028
183 1 0.776427 0.0255194 0.726410 0.82644
180 1 0.772114 0.0257396 0.721665 0.82256
175 1 0.767702 0.0259679 0.716806 0.81860
174 1 0.763290 0.0261908 0.711957 0.81462
167 1 0.758719 0.0264298 0.706918 0.81052
162 1 0.754036 0.0266783 0.701747 0.80632
159 2 0.744551 0.0271727 0.691293 0.79781
154 1 0.739716 0.0274230 0.685968 0.79346
148 1 0.734718 0.0276894 0.680448 0.78899
145 1 0.729651 0.0279582 0.674854 0.78445
142 1 0.724513 0.0282296 0.669184 0.77984
137 1 0.719224 0.0285146 0.663337 0.77511
128 1 0.713605 0.0288401 0.657080 0.77013
127 1 0.707986 0.0291553 0.650843 0.76513
126 1 0.702367 0.0294604 0.644626 0.76011
125 1 0.696749 0.0297557 0.638428 0.75507
114 1 0.690637 0.0301158 0.631611 0.74966
111 1 0.684415 0.0304805 0.624674 0.74416
109 1 0.678136 0.0308408 0.617689 0.73858
107 1 0.671798 0.0311970 0.610653 0.73294
98 1 0.664943 0.0316228 0.602963 0.72692
97 1 0.658088 0.0320312 0.595308 0.72087
92 1 0.650935 0.0324719 0.587291 0.71458
89 1 0.643621 0.0329204 0.579098 0.70814
85 1 0.636049 0.0333926 0.570601 0.70150
77 1 0.627788 0.0339653 0.561218 0.69436
76 1 0.619528 0.0345082 0.551893 0.68716
66 1 0.610141 0.0352389 0.541074 0.67921
62 1 0.600300 0.0360185 0.529705 0.67090
52 1 0.588756 0.0371298 0.515983 0.66153
51 1 0.577212 0.0381542 0.502431 0.65199
45 1 0.564385 0.0394035 0.487155 0.64161
44 1 0.551558 0.0405420 0.472097 0.63102
42 1 0.538426 0.0416493 0.456794 0.62006
40 1 0.524965 0.0427279 0.441220 0.60871
37 1 0.510777 0.0438656 0.424802 0.59675
34 1 0.495754 0.0450746 0.407409 0.58410
33 1 0.480731 0.0461443 0.390290 0.57117
31 1 0.465224 0.0471896 0.372734 0.55771
28 1 0.448608 0.0483409 0.353862 0.54335
24 1 0.429916 0.0498096 0.332291 0.52754
22 1 0.410375 0.0512357 0.309955 0.51079
20 1 0.389856 0.0526224 0.286718 0.49299
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APPENDIX j
EPI-INFO CALCULATIONS: 
PRIMARY BILIARY CIRRHOSIS BY GENDER 
FOR 312 PATIENTS
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Term Hazard Ratio
Sex(Yes/No) 0.9228
Age 1.0001
Albumin 0.3024
Alkaline 1.0051
Bili 1.4099
Platelets 0.9982
Spiders 1.4712
95%
0.4903
CJ.
1.7367
Coefficien
-0.0804
1.0001 1.0002 0.0001 .
0.1798 0.5086 -1.196
1.002 1.0081 0.0051
1.3181 1.508 0.3435
0.9963 1.0001 -0:0018
0.9356 2.3135 0.3861 o.:
S.E. Z-Statistic P-Value
0.3227 -0.2492 0.8032
0.0 4.2321 Oh
0.2653 -4.5083 Oh
0.0016 3.2592 0.0011
0.0343 10.0035 Oh
0.001 -1.8612 ’ 0.0627
1.6717 0.0946
Convergence: Diverged
Iterations: 2
-2 * Log-Likelihood: 1357.5497
Test Statistic D.F. P-Value
Score 261.9749 7 0.0
Likelihood Ratio -104.5501 7 1.0
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APPENDIX K
NONPARAMETRIC SURVIVAL PLOT 
FOR FOLLOW UP DAYS BY DRUG 
FOR 312 PATIENTS
68
Noriparametric Survival Plot for Follow U0 Days
Kaplan-Meier Method 
Censoring Column in Censor
Drug
---------- Placebo
--------- Penicillamine
Table of Statistics 
Mean Median IQR 
2746.18 3428 *
2833.04 3282 *
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APPENDIX L
EPI-INFO CALCULATIONS: 
PRIMARY BILIARY CIRRHOSIS BY DRUG 
FOR 312 PATIENTS
70
Term Hazard Ratio 95% C.I. Coefficient S. E. Z-Statistic P-Value
Drug(Y es/No) 0.9775 0.683 1.3991 -0.0227 0.1829 -0.1242 0.9011
Age 1.0001 1.0001 1.0002 0.0001 0.0 4.2723 09
Albumin 0.3059 0.1831 0.5111 -1.1844 0.2619 -4.5231 09
Alkaline 1.0052 1.0024 1.0081 0.0052 0.0014 3.6178 0.0003
Bili 1.4092 1.3176 1.5073 0.343 0.0343 9.9969 CKO
Platelets 0.9981 0.9963 1.0 -0.0019 0.001 -1.9534 0.0508
Spiders 1.4579 0.9318 2.2813 0.377 0.2284 1.6505 0.0988
Convergence: Diverged
Iterations: 2
■2 * Log-Likelihood: 1358.8139
Test Statistic D.F. P-Value
Score 261.9283 7 0.0
Likelihood Ratio -105.8143 7 1.0
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